Leaky gut and the liver: a role for bacterial translocation in nonalcoholic steatohepatitis
about
Gut Microbiota and Hepatocellular CarcinomaGut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemiaObesity, fatty liver disease and intestinal microbiotaSun Exposure and Its Effects on Human Health: Mechanisms through Which Sun Exposure Could Reduce the Risk of Developing Obesity and Cardiometabolic DysfunctionGut Microbiota and Host Reaction in Liver DiseasesImpact of birth weight and postnatal diet on the gut microbiota of young adult guinea pigsDevelopmental origins of NAFLD: a womb with a clue.Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation.Breath volatile organic compounds for the gut-fatty liver axis: promise, peril, and path forward.The Effect of DA-6034 on Intestinal Permeability in an Indomethacin-Induced Small Intestinal Injury Model.What does irritable bowel syndrome share with non-alcoholic fatty liver disease?Simultaneous gas-chromatographic urinary measurement of sugar probes to assess intestinal permeability: use of time course analysis to optimize its use to assess regional gut permeability.Rye affects bacterial translocation, intestinal viscosity, microbiota composition and bone mineralization in Turkey poults.Physiology and pathophysiology of liver lipid metabolism.CX3CR1 is a gatekeeper for intestinal barrier integrity in mice: Limiting steatohepatitis by maintaining intestinal homeostasis.Non-alcoholic fatty liver disease, diet and gut microbiota.Implications of microbiota and bile acid in liver injury and regeneration.Nonalcoholic fatty liver disease: Roles of the gut and the liver and metabolic modulation by some dietary factors and especially long-chain n-3 PUFA.On the translocation of bacteria and their lipopolysaccharides between blood and peripheral locations in chronic, inflammatory diseases: the central roles of LPS and LPS-induced cell death.Evaluation of a Bacillus direct-fed microbial candidate on digesta viscosity, bacterial translocation, microbiota composition and bone mineralisation in broiler chickens fed on a rye-based diet.Role of a Bacillus subtilis Direct-Fed Microbial on Digesta Viscosity, Bacterial Translocation, and Bone Mineralization in Turkey Poults Fed with a Rye-Based DietIdentification of Potential Biomarkers for Gut Barrier Failure in Broiler Chickens.Irritable Bowel Syndrome May Be Associated with Elevated Alanine Aminotransferase and Metabolic Syndrome.Analysis of the Bacterial Diversity in Liver Abscess: Differences Between Pyogenic and Amebic Abscesses.Sparstolonin B attenuates early liver inflammation in experimental NASH by modulating TLR4 trafficking in lipid rafts via NADPH oxidase activationMicrobiota and gut-liver axis: their influences on obesity and obesity-related liver diseaseHepatic function and the cardiometabolic syndrome.Nonalcoholic fatty liver disease is associated with benign gastrointestinal disorders.Associations between White Blood Cell Count and the Development of Incidental Nonalcoholic Fatty Liver Disease.Review article: novel methods for the treatment of non-alcoholic steatohepatitis - targeting the gut immune system to decrease the systemic inflammatory response without immune suppression.Shared symptoms and putative biological mechanisms in chronic liver disease: implications for biobehavioral research.Leaky Gut and Mycotoxins: Aflatoxin B1 Does Not Increase Gut Permeability in Broiler Chickens.Utilization of rye as energy source affects bacterial translocation, intestinal viscosity, microbiota composition, and bone mineralization in broiler chickensOptimizing Fluorescein Isothiocyanate Dextran Measurement As a Biomarker in a 24-h Feed Restriction Model to Induce Gut Permeability in Broiler Chickens.The gut-kidney axis in chronic renal failure: A new potential target for therapy.The effects of intestinal LPS exposure on inflammatory responses in a porcine enterohepatic co-culture system.Fructose and NAFLD: The Multifaceted Aspects of Fructose Metabolism.Hematopoietic plakophilin-3 regulates acute tissue-specific and systemic inflammation in mice.Fecal ESBL Escherichia coli carriage as a risk factor for bacteremia in patients with hematological malignancies.Dietary Composition Independent of Weight Loss in the Management of Non-Alcoholic Fatty Liver Disease.
P2860
Q26775568-321D3ACC-0EAA-4A17-A0A9-7568D09F8AC6Q26826919-0669BEFE-1178-460E-A38A-636831EC3215Q26997784-4C3AA9C5-44E3-4AF6-9593-A7A197FB5435Q28073380-672D0F86-DEF3-4FE2-BDDC-D14D70B32C7BQ28083295-9BB6F8AF-2713-43CF-ADA8-BDF77E084132Q28359717-EBDCA29F-3436-4140-9517-DF240576419CQ30241940-59D8A3BE-E83B-4D6F-A860-6F66AB4D08C2Q33755829-6816E2A7-1C71-4E8C-9237-684C6132A03BQ33958716-0C067BC3-1B15-4EB3-B482-BECAAC905DCCQ34523555-E0001D17-18A3-4E45-9E82-DEB86BABFC97Q34983471-6BF05D32-C81C-464D-A2FC-302C42134831Q35118493-C68DF788-68AA-4E7A-84F4-F9376686D8F6Q35301380-B08612AB-C534-4B77-A37F-87C567383464Q35662655-6998BA79-19DC-40E6-8551-DD973EFEFEB4Q35692948-1D8AFEFB-119F-4062-B01C-2A35F7B7C9DAQ35728214-FBF67CCA-B5D0-4F40-8534-E9F72FB6B60AQ35740865-6B55DB43-DA11-4353-97AB-EDAB39C74C9EQ35753377-AFCA8DC6-8448-44D7-88F9-1C7A2A04CC55Q35765830-F00631B7-11CE-4176-AB34-250A087CDEF9Q35833296-F5926868-C296-4CCD-8045-A25E4A4BBF9CQ36344707-49A951C2-971F-49A4-9995-78863623C883Q36353243-806BA947-2CE7-4BE9-A500-FC5294AB6F64Q36418677-12CE2675-176A-4192-BB4D-94256C36298DQ36455765-2FB5EC4B-2ADF-4259-B8CB-0CEFDFB9DF0FQ36775835-8BA5479F-08B4-416A-8702-7B87D2F6F8D5Q36798196-90287F05-EA8D-4620-AD0B-934FEB020041Q37232122-665B3CB4-E8AD-4A4C-8E32-189ED914F1DBQ37378928-204C1F02-1E4A-42A9-8608-55B0ED4C86D1Q37533461-C373AE1F-EF87-4701-87D2-60A3C1D14F08Q37563673-05AF081E-21A0-428A-B58F-92A2F7E0622FQ38231064-6214EC91-F87E-4BCB-842C-43921DC7A47AQ38410151-C7A7F6ED-5DFF-4974-95F7-60962D343328Q38415812-C890F5BC-829B-4D9E-8B8B-CCCB38C585E8Q38687921-B91DF60F-25DD-4B84-AEE2-513BD0B9A29FQ38955879-B9DCFD8B-8F2A-42E3-8A9D-6595350A0F75Q39094236-C847FD38-ECB0-440D-ADA9-92D4A506A310Q39168770-D1364A3B-F215-49A4-B772-9AA4BB9A3A6BQ40738118-3CE09FA3-D6EC-4D14-874C-607BF6BED1FFQ41201121-944DA058-14A7-4B3F-8682-F0DEFF2A21BFQ41583750-4B094E96-5B33-487A-B24C-6C140E23C334
P2860
Leaky gut and the liver: a role for bacterial translocation in nonalcoholic steatohepatitis
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Leaky gut and the liver: a rol ...... n nonalcoholic steatohepatitis
@ast
Leaky gut and the liver: a rol ...... n nonalcoholic steatohepatitis
@en
Leaky gut and the liver: a rol ...... n nonalcoholic steatohepatitis
@nl
type
label
Leaky gut and the liver: a rol ...... n nonalcoholic steatohepatitis
@ast
Leaky gut and the liver: a rol ...... n nonalcoholic steatohepatitis
@en
Leaky gut and the liver: a rol ...... n nonalcoholic steatohepatitis
@nl
prefLabel
Leaky gut and the liver: a rol ...... n nonalcoholic steatohepatitis
@ast
Leaky gut and the liver: a rol ...... n nonalcoholic steatohepatitis
@en
Leaky gut and the liver: a rol ...... n nonalcoholic steatohepatitis
@nl
P2860
P3181
P356
P1476
Leaky gut and the liver: a rol ...... n nonalcoholic steatohepatitis
@en
P2093
Yaron Ilan
P2860
P304
P3181
P356
10.3748/WJG.V18.I21.2609
P407
P577
2012-06-07T00:00:00Z